✦ LIBER ✦

O-111 Docetaxel and COX-2 inhibition with celecoxib in progressive non-small cell lung cancer (NSCLC): Promising progression-free survival in a phase II study

✍ Scribed by Nugent, Francis W.; Graziano, Stephen; Collea, Rufus; Levitan, Nathan; Gajra, Ajeet; Freeman, John; O'Connell, Cathy; Marshall, Janine; Mertens, Wilson; McCann, John

Book ID: 118571502
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 367 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91769-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and cyclooxygenase-2 inhibitio

Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial

✍ Nugent, Francis W.; Mertens, Wilson C.; Graziano, Stephen; Levitan, Nathan; Coll 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 156 KB

O-239 Gemcitabine in the treatment of no

O-239 Gemcitabine in the treatment of non-small cell lung cancer (NSCLC): A meta-analysis of survival and progression free survival data

✍ Le Chevalier, T.; Brown, A.; Natale, R.; Scagliotti, G.; Vansteenkiste, J.; Van 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

O-110 Preliminary results of a phase II

O-110 Preliminary results of a phase II study of celecoxib and weekly docetaxel in elderly (> 70 yrs) or PS2 patients with advanced non-small cell lung cancer (NSCLC)

✍ Gadgeel, Shirish M.; Shehadeh, Nasfet; Kraut, Michael J.; Wozniak, Antoinette; B 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

P-559 A phase II study of oxallplatln an

P-559 A phase II study of oxallplatln and docetaxel In patients with advanced non-small-cell lung cancer (NSCLC)

✍ Raez, L.; Santos, E.; Rocha-Lima, C.; Roman, E.; Kumar, P.; Farfan, N.; Decesare 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A phase II study of modulated-capecitabi

A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)

✍ Bertino, Erin M.; Bekaii-Saab, Tanios; Fernandez, Soledad; Diasio, Robert B.; Ka 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 252 KB

A phase I–II study of docetaxel (D) and

A phase I–II study of docetaxel (D) and gemcitabine (G) combination in patients (pts) with non-small cell lung cancer (NSCLC)

✍ Quantin, X; Rebattu, P; Pujol, J; Morere, J; Azarian, M.R; Khial, F; Dumortier, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB